Related Experiment Videos

Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series

Martijn Weisfelt1, Diederik van de Beek, Lodewijk Spanjaard

  • 1Department of Neurology, Centre of Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre, 1100 DD Amsterdam, Netherlands.

The Lancet. Neurology
|January 24, 2006
PubMed
Abstract

Insights

Pneumococcal meningitis in adults has high mortality and morbidity. Neurological complications cause death in younger patients, while systemic issues are the main cause of death in older adults.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Critical Care Medicine

Background:

  • Bacterial meningitis, particularly pneumococcal meningitis, presents a significant global health challenge with high incidence rates, especially in developing nations.
  • This study focuses on the clinical presentation, complications, prognostic factors, and outcomes of pneumococcal meningitis in adult patients.

Purpose of the Study:

  • To elucidate the clinical characteristics, spectrum of complications, and prognostic indicators associated with pneumococcal meningitis in adults.
  • To identify predictors of unfavorable outcomes and analyze mortality patterns in different age groups.

Main Methods:

  • A cohort of 352 adult patients (older than 16 years) with culture-confirmed community-acquired pneumococcal meningitis was assessed between October 1998 and April 2002.
  • Logistic regression with multiple imputation techniques was employed to identify predictors of unfavorable outcomes (Glasgow Outcome Scale score 1-4).
  • Cranial computed tomography (CT) scans were utilized to identify underlying disorders and intracranial complications.

Main Results:

  • Seventy percent of pneumococcal meningitis episodes were linked to an underlying disorder. Cranial CT revealed complications in 39% of cases.
  • Independent predictors for poor outcomes included low Glasgow Coma Scale score, cranial nerve palsies, elevated erythrocyte sedimentation rate, low cerebrospinal fluid (CSF) leukocyte count (<1000 cells/mm³), and high CSF protein concentration.
  • Overall in-hospital mortality was 30%. Neurological complications predominated as the cause of death in younger patients, whereas systemic complications were more frequent in older patients (≥60 years).

Conclusions:

  • Pneumococcal meningitis in adults is associated with substantial mortality and morbidity.
  • The leading causes of death differ significantly between younger and elderly patients, with neurological complications in the young and systemic complications in the elderly.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...